Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Knight Therapeutics Inc. T.GUD

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic

Price: $6.76 | Change: $-0.04 | %Change: -0.59%
Volume: 81,755 | Day High/Low: 6.89/6.76 | 52 Week High/Low: 7.24/3.51
View modes: 
5 stars

All About Partnering on Web Site"

Nothing new here, it's a natural process for them to grow.  http://www.gud-knight.com/en/partnering  rate and reply
3 stars

Confused...see this comment from the news release...

See...if it were just investment, a comment like this would not be made...  "Sanderling is thrilled to partner with Knight in the development and distribution of innovative therapeutics and medical...read more
0 stars

RE:RE:Today's Globe & Mail Small Caps to Watch

I don't think it's short-term investments. I think it's long-term. Creating a presence with each of these investment teams. Almost like developing a scouting network for good drug candidates. With...read more
1 star

RE:Today's Globe & Mail Small Caps to Watch

Putting our money to short term work while they establish their first acquisition..  rate and reply
0 stars

Today's Globe & Mail Small Caps to Watch

Knight Therapeutics Inc. said it will invest a total of $35-million (U.S.) in two funds that take positions in and provide early-stage financing to life science and biomedical firms. The company plans...read more
0 stars

News Out

http://www.marketwired.com/press-release/knight-further-executes-its-innovative-pharmaceutical-product-sourcing-strategy-tsx-gud-1977166.htm  rate and reply
0 stars

Smedley Talks...doesn't really say anything...again!

"This keeps doing very interesting things like buying chunks of very highly specialized funds, which leads them into products eventually. Recently did an issue, which was heavily subscribed. He did...read more
5 stars

Management Team Addition...

Might not be new to some of you but I just paid attention to this addition... Business Development is getting underway...from Paladin Labs Amal Khouri Vice President of Business Development ...read more
4.5 stars

Latest Board Member...

In pharma market research...makes sense! Ms. Tendler is a leading pharmaceutical market research specialist and entrepreneur. In 2001, she founded The Tendler Group, a custom marketing research...read more
0 stars

RE:RE:Thoughts...

Thanks Smithwicks...I'm also thinking we need to wait for the deal to go through and then I wouldn't expect much until 2015. Though...I'd love an early Christmas present from J.Goodman...read more
3 stars

RE:Thoughts...

I dont believe we will see any big deals until the pp closes.  Its obvious that the price is being controlled to the 6.75 level and i think it will stay there for the next few weeks.  The big deal is...read more
0 stars

Thoughts...

$100M deal closes Dec 22. Will there be any news before that or are we into late December or January before we hear anything? Thoughts?  rate and reply
0 stars

5 MBAs on the Management Team...

There are 5 on the management team now. All with MBA degrees - 4 McGill and 1 INSEAD. All 5 have McGill roots. Reminds me of what Paladin looked like. "Big Deal" you say! I think it is...a...read more
0 stars

i realize a few weeks old but still worth a read.

Knight Therapeutics sells fast-track drug certificate RICHARD BLACKWELL The Globe and Mail Published  Wednesday, Nov. 19 2014, 12:39 PM...read more
0 stars

RE:So far

He's good at finding opportunities in the pharma space. Pharma has proven to be a great space for Goodman and for Paladin. Most importantly... Owning Paladin Shares became a great hedge against...read more
0 stars

So far

It looks like this guy is a serial market miner.  rate and reply
3 stars

Bought Deal....

If the underwriters exercise their over-allotment option GUD could be looking at $100,002,735 This CEO did it once with Paladin Labs and he will do it again ,only this time it will be with...read more
5 stars

RE:What does this bought deal mean for GUD and retail investors

It is a dilution of shares...look at previous news releases for this company to see previous bought deals at lower prices. Bought deals occur because the buyer sees a demand for these shares...either...read more
0 stars

RE:What does this bought deal mean for GUD and retail investors

As another neophyte in the investing game, those same questions crossed my mind as well. Thanks for asking them. Looking forward to some responses.  rate and reply
5 stars

What does this bought deal mean for GUD and retail investors

Hey guys, I'm still quite new to investing and have a few questions. From what I understand, the bought deal was basically GUD offered up to several million new shares at a price of $6.75 to a...read more